	自己資本および準備金		日付
AbbVie	USD -3.27B	628M	2025-12
Acadia Pharmaceuticals	USD 917.27M	94.89M	2025-09
Agios Pharmaceuticals	USD 1.19B	91.22M	2025-12
ALKERMES	USD 1.82B	85.86M	2025-12
Alnylam Pharmaceuticals	USD 789.18M	555.28M	2025-12
Amgen	USD 8.66B	961M	2025-12
Biogen	USD 18.21B	573.5M	2025-09
BioMarin Pharmaceutical	USD 6.09B	30.29M	2025-12
Cytokinetics	USD -659.62M	138.5M	2025-12
Enanta Pharmaceuticals	USD 126.59M	61.87M	2025-12
Exelixis	USD 2.16B	619K	2025-12
Gilead Sciences	USD 22.62B	1.16B	2025-12
Halozyme Therapeutics	USD 48.81M	455.1M	2025-12
Incyte	USD 5.17B	516.28M	2025-12
Ionis Pharmaceuticals	USD 617.97M	13.76M	2025-09
Nektar Therapeutics	USD 89.83M	4.75M	2025-12
Neurocrine Biosciences	USD 3.25B	249.5M	2025-12
Pfizer	USD 92.8B	4.11B	2025-09
Prothena	USD 280.47M	14.51M	2025-12
Regeneron Pharmaceuticals	USD 31.26B	299.1M	2025-12
Repligen	USD 2.11B	1.66B	2025-12
Rigel Pharmaceuticals	USD 117.61M	35.67M	2025-09
Sarepta Therapeutics	USD 1.14B	179.5M	2025-12
Teva Pharmaceutical Industries	USD 7.91B	664M	2025-12
Ultragenyx Pharmaceutical	USD 9.16M	142.13M	2025-09
Vertex Pharmaceuticals	USD 18.67B	1.35B	2025-12
Xoma	USD 87.94M	15.5M	2025-09